Cour Pharmaceutical

Biotech · Private

Tolerogenic nanoparticles that induce antigen-specific immune tolerance

courpharma.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2241POWERHOUSE PROTEOMIC SYSTEMS, LLC——
2242TENSIVE CONTROLS, INC.——
2243Acelyrin——
2244Cour Pharmaceutical——
2245AVEXEGEN THERAPEUTICS INC.——
2246CELLF-BIO LLC——
2247NOUR HEART, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.